Rankings
▼
Calendar
FDMT FY 2020 Earnings — 4D Molecular Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
FDMT
4D Molecular Therapeutics, Inc.
$427M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
+94.8% YoY
Gross Profit
-$39M
-289.6% margin
Operating Income
-$57M
-416.3% margin
Net Income
-$57M
-416.5% margin
EPS (Diluted)
$-2.12
Cash Flow
Operating Cash Flow
-$51M
Free Cash Flow
-$52M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$288M
Total Liabilities
$32M
Stockholders' Equity
$256M
Cash & Equivalents
$277M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$7M
+94.8%
Gross Profit
-$39M
-$32M
-24.2%
Operating Income
-$57M
-$51M
-11.6%
Net Income
-$57M
-$49M
-15.0%
← Q4 2019
All Quarters
Q1 2020 →